CMS updated its Open Payments data June 30, including information on how much orthopedic and spine device companies paid to partnering physicians and institutions.
The Open Payments data has tracked financial compensation over $10 from medical device and pharmaceutical companies since 2016. The most recent data published was reported for the 2022 calendar year.
Below is the amount of money seven orthopedic device companies disclosed in payments to physicians, clincians and healthcare organizations in the last year.
|Company||General||Research||Royalty or license|
|Medtronic||$126.1 million||$54.4 million||$41.6 million|
|DePuy Synthes||$125.6 million||$291,410||$72.5 million|
|Stryker||$112.3 million||$6.7 million||$68.9 million|
|Smith + Nephew||$73.4 million||$4.4 million||$38.2 million|
|Zimmer Biomet||$59 million||$4.7 million||$39.3 million|
|Globus Medical||$16.2 million||$129,748||$10.9 million|
|NuVasive||$16.2 million||$1.5 million||$9.6 million|